• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用对接方法探索蛋白质-蛋白质相互作用表面:在蛋白质-蛋白质相互作用抑制剂设计中的应用

Surfing the Protein-Protein Interaction Surface Using Docking Methods: Application to the Design of PPI Inhibitors.

作者信息

Sable Rushikesh, Jois Seetharama

机构信息

Department of Basic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, LA 71201, USA.

出版信息

Molecules. 2015 Jun 23;20(6):11569-603. doi: 10.3390/molecules200611569.

DOI:10.3390/molecules200611569
PMID:26111183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6272567/
Abstract

Blocking protein-protein interactions (PPI) using small molecules or peptides modulates biochemical pathways and has therapeutic significance. PPI inhibition for designing drug-like molecules is a new area that has been explored extensively during the last decade. Considering the number of available PPI inhibitor databases and the limited number of 3D structures available for proteins, docking and scoring methods play a major role in designing PPI inhibitors as well as stabilizers. Docking methods are used in the design of PPI inhibitors at several stages of finding a lead compound, including modeling the protein complex, screening for hot spots on the protein-protein interaction interface and screening small molecules or peptides that bind to the PPI interface. There are three major challenges to the use of docking on the relatively flat surfaces of PPI. In this review we will provide some examples of the use of docking in PPI inhibitor design as well as its limitations. The combination of experimental and docking methods with improved scoring function has thus far resulted in few success stories of PPI inhibitors for therapeutic purposes. Docking algorithms used for PPI are in the early stages, however, and as more data are available docking will become a highly promising area in the design of PPI inhibitors or stabilizers.

摘要

使用小分子或肽阻断蛋白质 - 蛋白质相互作用(PPI)可调节生化途径并具有治疗意义。设计类药物分子的PPI抑制是过去十年中广泛探索的一个新领域。考虑到可用的PPI抑制剂数据库数量以及蛋白质可用的3D结构数量有限,对接和评分方法在设计PPI抑制剂以及稳定剂方面发挥着重要作用。对接方法在寻找先导化合物的几个阶段用于PPI抑制剂的设计,包括对蛋白质复合物进行建模、在蛋白质 - 蛋白质相互作用界面上筛选热点以及筛选与PPI界面结合的小分子或肽。在PPI相对平坦的表面上使用对接存在三个主要挑战。在本综述中,我们将提供一些在PPI抑制剂设计中使用对接的示例及其局限性。到目前为止,将实验和对接方法与改进的评分函数相结合,在用于治疗目的的PPI抑制剂方面取得的成功案例很少。然而,用于PPI的对接算法尚处于早期阶段,随着更多数据可用,对接将成为PPI抑制剂或稳定剂设计中一个非常有前景的领域。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/6272567/a4c62191ca16/molecules-20-11569-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/6272567/f634161d24f6/molecules-20-11569-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/6272567/3f46c9edee63/molecules-20-11569-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/6272567/720cbb0f8732/molecules-20-11569-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/6272567/348ba0cb81c1/molecules-20-11569-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/6272567/ea4ce5324153/molecules-20-11569-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/6272567/a4c62191ca16/molecules-20-11569-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/6272567/f634161d24f6/molecules-20-11569-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/6272567/3f46c9edee63/molecules-20-11569-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/6272567/720cbb0f8732/molecules-20-11569-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/6272567/348ba0cb81c1/molecules-20-11569-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/6272567/ea4ce5324153/molecules-20-11569-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/6272567/a4c62191ca16/molecules-20-11569-g006.jpg

相似文献

1
Surfing the Protein-Protein Interaction Surface Using Docking Methods: Application to the Design of PPI Inhibitors.使用对接方法探索蛋白质-蛋白质相互作用表面:在蛋白质-蛋白质相互作用抑制剂设计中的应用
Molecules. 2015 Jun 23;20(6):11569-603. doi: 10.3390/molecules200611569.
2
In silico structure-based approaches to discover protein-protein interaction-targeting drugs.基于结构的计算方法在发现靶向蛋白-蛋白相互作用药物中的应用。
Methods. 2017 Dec 1;131:22-32. doi: 10.1016/j.ymeth.2017.08.006. Epub 2017 Aug 9.
3
Fast Rescoring Protocols to Improve the Performance of Structure-Based Virtual Screening Performed on Protein-Protein Interfaces.快速重评分协议可改善基于结构的蛋白质-蛋白质界面虚拟筛选的性能。
J Chem Inf Model. 2020 Aug 24;60(8):3910-3934. doi: 10.1021/acs.jcim.0c00545. Epub 2020 Aug 11.
4
A novel small-molecule PPI inhibitor targeting integrin αvβ3-osteopontin interface blocks bone resorption in vitro and prevents bone loss in mice.一种新型小分子 PPI 抑制剂,靶向整合素 αvβ3-骨桥蛋白界面,可在体外抑制骨吸收,并预防小鼠的骨丢失。
Biomaterials. 2016 Aug;98:131-42. doi: 10.1016/j.biomaterials.2016.05.007. Epub 2016 May 5.
5
Benchmark Study Based on 2P2I to Gain Insights into the Discovery of Small-Molecule PPI Inhibitors.基于 2P2I 的基准研究,深入了解小分子 PPI 抑制剂的发现。
J Phys Chem B. 2018 Mar 8;122(9):2544-2555. doi: 10.1021/acs.jpcb.7b12658. Epub 2018 Feb 22.
6
A combination of in silico and SAR studies to identify binding hot spots of Bcl-xL inhibitors.通过计算机模拟和构效关系研究相结合来确定Bcl-xL抑制剂的结合热点。
Bioorg Med Chem. 2015 Apr 15;23(8):1747-57. doi: 10.1016/j.bmc.2015.02.060. Epub 2015 Mar 6.
7
Identification of Inhibitors for the Lutheran Blood Group Glycoprotein - Laminin 511/521 Interaction by Molecular Modelling and Simulation Techniques.通过分子建模和模拟技术鉴定路德血型糖蛋白与层粘连蛋白511/521相互作用的抑制剂
Curr Comput Aided Drug Des. 2018;14(3):253-268. doi: 10.2174/1573409912666160719093244.
8
Structure-based computational approaches for small-molecule modulation of protein-protein interactions.基于结构的小分子调节蛋白质-蛋白质相互作用的计算方法。
Methods Mol Biol. 2015;1278:77-92. doi: 10.1007/978-1-4939-2425-7_5.
9
State-of-the-art strategies for targeting protein-protein interactions by small-molecule inhibitors.靶向小分子抑制剂的蛋白质-蛋白质相互作用的最新策略。
Chem Soc Rev. 2015 Nov 21;44(22):8238-59. doi: 10.1039/c5cs00252d. Epub 2015 Aug 6.
10
Stabilization of protein-protein interaction complexes through small molecules.小分子稳定蛋白质-蛋白质相互作用复合物。
Drug Discov Today. 2016 Jan;21(1):48-57. doi: 10.1016/j.drudis.2015.09.011. Epub 2015 Oct 3.

引用本文的文献

1
In Silico Identification of Potential Antagonists Targeting the HPV16 E2-E1 Interaction: A Step Toward Novel Therapeutics for Cervical Cancer.靶向人乳头瘤病毒16型E2-E1相互作用的潜在拮抗剂的计算机模拟鉴定:迈向宫颈癌新型疗法的一步
Curr Issues Mol Biol. 2025 Apr 18;47(4):288. doi: 10.3390/cimb47040288.
2
AmNA-Modified Antisense Oligonucleotide Targeting MCM8 as a Cancer-Specific Chemosensitizer for Platinum Compounds.靶向MCM8的氨基萘甲酰(AmNA)修饰反义寡核苷酸作为铂类化合物的癌症特异性化学增敏剂
Cancer Sci. 2025 May;116(5):1405-1416. doi: 10.1111/cas.70024. Epub 2025 Mar 17.
3
Polymers for Disrupting Protein-Protein Interactions: Where Are We and Where Should We Be?

本文引用的文献

1
Alternative modulation of protein-protein interactions by small molecules.小分子对蛋白质-蛋白质相互作用的选择性调控
Curr Opin Biotechnol. 2015 Dec;35:78-85. doi: 10.1016/j.copbio.2015.04.006. Epub 2015 May 15.
2
Computational and biophysical approaches to protein-protein interaction inhibition of Plasmodium falciparum AMA1/RON2 complex.恶性疟原虫AMA1/RON2复合物蛋白质-蛋白质相互作用抑制的计算和生物物理方法
J Comput Aided Mol Des. 2015 Jun;29(6):525-39. doi: 10.1007/s10822-015-9842-7. Epub 2015 Mar 31.
3
In silico design of low molecular weight protein-protein interaction inhibitors: Overall concept and recent advances.
聚合物类药物干扰蛋白-蛋白相互作用:路在何方?
Biomacromolecules. 2024 Oct 14;25(10):6229-6249. doi: 10.1021/acs.biomac.4c00850. Epub 2024 Sep 10.
4
Strategies for converting turn-motif and cyclic peptides to small molecules for targeting protein-protein interactions.将转角基序和环肽转化为用于靶向蛋白质-蛋白质相互作用的小分子的策略。
RSC Chem Biol. 2024 Feb 16;5(3):198-208. doi: 10.1039/d3cb00222e. eCollection 2024 Mar 6.
5
Structure-based drug design and molecular dynamics studies of an allosteric modulator targeting the protein-protein interaction site of PDK1.基于结构的药物设计和针对 PDK1 蛋白-蛋白相互作用位点的别构调节剂的分子动力学研究。
J Mol Model. 2024 Jan 26;30(2):51. doi: 10.1007/s00894-024-05842-2.
6
Molecular Dynamics and Other HPC Simulations for Drug Discovery.药物发现的分子动力学和其他高性能计算模拟。
Methods Mol Biol. 2024;2716:265-291. doi: 10.1007/978-1-0716-3449-3_12.
7
A New Tool to Study the Binding Behavior of Intrinsically Disordered Proteins.一种研究无规卷曲蛋白质结合行为的新工具。
Int J Mol Sci. 2023 Jul 22;24(14):11785. doi: 10.3390/ijms241411785.
8
Design and Synthesis of Novel Helix Mimetics Based on the Covalent H-Bond Replacement and Amide Surrogate.基于共价氢键取代和酰胺替代的新型螺旋类似物的设计与合成。
Molecules. 2023 Jan 12;28(2):780. doi: 10.3390/molecules28020780.
9
A Modular Synthesis of Teraryl-Based α-Helix Mimetics, Part 4: Core Fragments with Two Halide Leaving Groups Featuring Side Chains of Proteinogenic Amino Acids.基于三联芳基的α-螺旋模拟物的模块化合成,第4部分:带有两个卤化物离去基团且具有蛋白质氨基酸侧链的核心片段
European J Org Chem. 2022 May 6;2022(17):e202101279. doi: 10.1002/ejoc.202101279. Epub 2022 Feb 24.
10
Systematic Tracing of Susceptible Animals to SARS-CoV-2 by a Bioinformatics Framework.通过生物信息学框架对感染 SARS-CoV-2 易感动物进行系统追踪
Front Microbiol. 2022 Mar 4;13:781770. doi: 10.3389/fmicb.2022.781770. eCollection 2022.
低分子量蛋白质-蛋白质相互作用抑制剂的计算机辅助设计:总体概念与最新进展
Prog Biophys Mol Biol. 2015 Oct;119(1):20-32. doi: 10.1016/j.pbiomolbio.2015.02.006. Epub 2015 Mar 5.
4
Protein models docking benchmark 2.蛋白质模型对接基准测试2
Proteins. 2015 May;83(5):891-7. doi: 10.1002/prot.24784. Epub 2015 Mar 25.
5
Flexibility and small pockets at protein-protein interfaces: New insights into druggability.蛋白质-蛋白质界面的灵活性和微小口袋:药物可及性的新见解
Prog Biophys Mol Biol. 2015 Oct;119(1):2-9. doi: 10.1016/j.pbiomolbio.2015.01.009. Epub 2015 Feb 7.
6
Recent advances in virtual screening for drug discovery.药物发现虚拟筛选的最新进展。
Methods. 2015 Jan;71:1-3. doi: 10.1016/j.ymeth.2014.12.012.
7
CONSRANK: a server for the analysis, comparison and ranking of docking models based on inter-residue contacts.CONSRANK:一个基于残基间接触的对接模型分析、比较和排序的服务器。
Bioinformatics. 2015 May 1;31(9):1481-3. doi: 10.1093/bioinformatics/btu837. Epub 2014 Dec 21.
8
The BioGRID interaction database: 2015 update.生物通用互作数据库:2015年更新版
Nucleic Acids Res. 2015 Jan;43(Database issue):D470-8. doi: 10.1093/nar/gku1204. Epub 2014 Nov 26.
9
Small-molecule inhibitors of the MDM2-p53 protein-protein interaction (MDM2 Inhibitors) in clinical trials for cancer treatment.用于癌症治疗临床试验的MDM2-p53蛋白-蛋白相互作用小分子抑制剂(MDM2抑制剂)。
J Med Chem. 2015 Feb 12;58(3):1038-52. doi: 10.1021/jm501092z. Epub 2014 Nov 14.
10
Novel Peptidomimetics for Inhibition of HER2:HER3 Heterodimerization in HER2-Positive Breast Cancer.用于抑制HER2阳性乳腺癌中HER2:HER3异二聚化的新型拟肽
Chem Biol Drug Des. 2015 Jun;85(6):702-714. doi: 10.1111/cbdd.12453. Epub 2014 Nov 6.